PDB: 9760 resultsInfo pagesStatus searchChemie searchBIRD

---

7RDK	Crystal structure of PCDN-16B, an anti-HIV antibody from the PCDN bnAb lineage (cysteinylated state) Descriptor: 1,2-ETHANEDIOL, CYSTEINE, GLYCEROL, ... Authors: Omorodion, O, Wilson, I.A. Deposit date: 2021-07-09 Release date: 2021-11-10 Last modified: 2023-10-18 Method: X-RAY DIFFRACTION (2.46 Å) Cite: Structural and Biochemical Characterization of Cysteinylation in Broadly Neutralizing Antibodies to HIV-1. J.Mol.Biol., 433, 2021
7RLZ	Antibody 2F2 in complex with P. vivax CSP peptide GDRAAGQPAGNGAGGQAA Descriptor: 2F2 Fab heavy chain, 2F2 Fab light chain, peptide from Circumsporozoite protein variant VK210 Authors: Kucharska, I, Julien, J.P. Deposit date: 2021-07-26 Release date: 2022-01-26 Method: X-RAY DIFFRACTION (2.27 Å) Cite: Structural basis of Plasmodium vivax inhibition by antibodies binding to the circumsporozoite protein repeats. Elife, 11, 2022
7RM1	Antibody 2F2 in complex with P. vivax CSP peptide EDGAGNQPGANGAGNQPGANGAGNQPG Descriptor: 2E10.E9 Fab heavy chain, 2E10.E9 Fab light chain, peptide from Circumsporozoite protein variant VK247 Authors: Kucharska, I, Ivanochko, D, Julien, J.P. Deposit date: 2021-07-26 Release date: 2022-01-26 Last modified: 2023-10-18 Method: X-RAY DIFFRACTION (3.19 Å) Cite: Structural basis of Plasmodium vivax inhibition by antibodies binding to the circumsporozoite protein repeats. Elife, 11, 2022
7RLX	Antibody 2F2 in complex with P. vivax CSP peptide GDRADGQPAGDRAAGQPA Descriptor: 2F2 Fab heavy chain, 2F2 Fab light chain, peptide from Circumsporozoite protein variant VK210 Authors: Kucharska, I, Julien, J.P. Deposit date: 2021-07-26 Release date: 2022-01-26 Last modified: 2023-10-18 Method: X-RAY DIFFRACTION (1.97 Å) Cite: Structural basis of Plasmodium vivax inhibition by antibodies binding to the circumsporozoite protein repeats. Elife, 11, 2022
7RLV	Antibody 2F2 in complex with P. vivax CSP peptide GDRADGQPAGDRADGQPA Descriptor: 1,2-ETHANEDIOL, 2F2 Fab heavy chain, 2F2 Fab light chain, ... Authors: Kucharska, I, Julien, J.P. Deposit date: 2021-07-26 Release date: 2022-01-26 Last modified: 2023-10-18 Method: X-RAY DIFFRACTION (2.2 Å) Cite: Structural basis of Plasmodium vivax inhibition by antibodies binding to the circumsporozoite protein repeats. Elife, 11, 2022
7RM0	Antibody 2E10.E9 in complex with P. vivax CSP peptide ANGAGNQPGANGAGNQPG Descriptor: 2E10.E9 Fab heavy chain, 2E10.E9 Fab light chain, peptide from Circumsporozoite protein variant VK247 Authors: Kucharska, I, Ivanochko, D, Julien, J.P. Deposit date: 2021-07-26 Release date: 2022-01-26 Last modified: 2023-10-18 Method: X-RAY DIFFRACTION (2.71 Å) Cite: Structural basis of Plasmodium vivax inhibition by antibodies binding to the circumsporozoite protein repeats. Elife, 11, 2022
7RLW	Antibody 2F2 in complex with P. vivax CSP peptide GDRAAGQPAGDRAAGQPA Descriptor: 2F2 Fab heavy chain, 2F2 Fab light chain, PvCSPvk210 peptide from Circumsporozoite protein Authors: Kucharska, I, Julien, J.P. Deposit date: 2021-07-26 Release date: 2022-01-26 Last modified: 2023-10-18 Method: X-RAY DIFFRACTION (2.54 Å) Cite: Structural basis of Plasmodium vivax inhibition by antibodies binding to the circumsporozoite protein repeats. Elife, 11, 2022
7RLY	Antibody 2F2 in complex with P. vivax CSP peptide DRAAGQPAGDRADGQPA Descriptor: 2F2 Fab heavy chain, 2F2 Fab light chain, peptide from Circumsporozoite protein variant VK210 Authors: Kucharska, I, Julien, J.P. Deposit date: 2021-07-26 Release date: 2022-01-26 Last modified: 2023-10-18 Method: X-RAY DIFFRACTION (2.67 Å) Cite: Structural basis of Plasmodium vivax inhibition by antibodies binding to the circumsporozoite protein repeats. Elife, 11, 2022
7RM3	Antibody 2E10.E9 in complex with P. vivax CSP peptide ANGAGNQPGANGAGNQPGANGAGGQAA Descriptor: 2E10.E9 Fab heavy chain, 2E10.E9 Fab light chain, ACETATE ION, ... Authors: Kucharska, I, Ivanochko, D, Julien, J.P. Deposit date: 2021-07-26 Release date: 2022-01-26 Last modified: 2023-10-18 Method: X-RAY DIFFRACTION (2.68 Å) Cite: Structural basis of Plasmodium vivax inhibition by antibodies binding to the circumsporozoite protein repeats. Elife, 11, 2022
7KEW	Bundibugyo virus GP (mucin deleted) bound to antibody Fab BDBV-43 Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, BDBV-43 Fab heavy chain, ... Authors: Murin, C.D, Ward, A.B. Deposit date: 2020-10-13 Release date: 2021-04-28 Method: ELECTRON MICROSCOPY (4.16 Å) Cite: Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies. Cell Rep, 35, 2021
8F2T	Antibody Fab directed against SARS-CoV-2 Spike Protein Receptor Binding Domain (RBD) Descriptor: Fab heavy chain, Fab light chain Authors: Chen, J.C.-H. Deposit date: 2022-11-08 Release date: 2023-12-13 Method: X-RAY DIFFRACTION (2.12 Å) Cite: Antibody Fab directed against SARS-CoV-2 Spike Protein Receptor Binding Domain (RBD) To Be Published
8F2V	Antibody Fab directed against SARS-CoV-2 Spike Protein Receptor Binding Domain (RBD) Descriptor: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID, Fab heavy chain, Fab light chain Authors: Chen, J.C.-H. Deposit date: 2022-11-08 Release date: 2023-12-13 Method: X-RAY DIFFRACTION (3.5 Å) Cite: Antibody Fab directed against SARS-CoV-2 Spike Protein Receptor Binding Domain (RBD) To Be Published
7TRH	Human antibody K03.28 in complex with the influenza hemagglutinin head domain of A/California/07/2009(H1N1)(X-181) Descriptor: Hemagglutinin, K03.28 Fab heavy chain, K03.28 Fab lambda light chain Authors: McCarthy, K.R. Deposit date: 2022-01-28 Release date: 2023-08-02 Last modified: 2024-01-03 Method: X-RAY DIFFRACTION (3 Å) Cite: A new class of antibodies that overcomes a steric barrier to cross-group neutralization of influenza viruses. Plos Biol., 21, 2023
7TRI	Human antibody S8V1-172 in complex with the influenza hemagglutinin head domain of A/Sydney/05/1997(H3N2) Descriptor: Hemagglutinin, S8V1-172 Fab heavy chain, S8V1-172 Fab kappa light chain, ... Authors: McCarthy, K.R. Deposit date: 2022-01-28 Release date: 2023-08-02 Last modified: 2024-01-03 Method: X-RAY DIFFRACTION (3.6 Å) Cite: A new class of antibodies that overcomes a steric barrier to cross-group neutralization of influenza viruses. Plos Biol., 21, 2023
7T98	Crystal structure of engineered CYS-CYS fab dimer VL-108 (LC33) Descriptor: FAB Heavy Chain, FAB Light Chain Authors: Harris, S.F, Boenig, G.D.L. Deposit date: 2021-12-18 Release date: 2022-10-12 Method: X-RAY DIFFRACTION (2.97 Å) Cite: Antibody interfaces revealed through structural mining. Comput Struct Biotechnol J, 20, 2022
7T97	Crystal structure of engineered CYS-CYS fab dimer CH1-207 (HC4) Descriptor: FAB Heavy chain, FAB Light Chain Authors: Harris, S.F, Boenig, G.D.L. Deposit date: 2021-12-18 Release date: 2022-10-12 Method: X-RAY DIFFRACTION (2.144 Å) Cite: Antibody interfaces revealed through structural mining. Comput Struct Biotechnol J, 20, 2022
7T99	Crystal structure of engineered CYS-CYS fab dimer CL-205 (LC25) Descriptor: FAB Heavy Chain, FAB Light Chain, PHOSPHATE ION Authors: Harris, S.F, Boenig, G.D.L. Deposit date: 2021-12-18 Release date: 2022-10-12 Method: X-RAY DIFFRACTION (2.65 Å) Cite: Antibody interfaces revealed through structural mining. Comput Struct Biotechnol J, 20, 2022
3K7U	Structure of essential protein from Trypanosoma brucei Descriptor: Antibody, MP18 RNA editing complex protein Authors: Wu, M. Deposit date: 2009-10-13 Release date: 2010-11-17 Last modified: 2023-09-06 Method: X-RAY DIFFRACTION (2.1 Å) Cite: Structures of a key interaction protein from the Trypanosoma brucei editosome in complex with single domain antibodies. J.Struct.Biol., 174, 2011
3K80	Structure of essential protein from Trypanosoma brucei Descriptor: Antibody, MP18 RNA editing complex protein Authors: Wu, M. Deposit date: 2009-10-13 Release date: 2010-11-17 Last modified: 2023-09-06 Method: X-RAY DIFFRACTION (2.4 Å) Cite: Structures of a key interaction protein from the Trypanosoma brucei editosome in complex with single domain antibodies. J.Struct.Biol., 174, 2011
7JKB	2xVH Fab Descriptor: Anti-Her2, Anti-lysozyme Authors: Lord, D.M, Zhou, Y.F. Deposit date: 2020-07-28 Release date: 2020-11-25 Last modified: 2024-04-03 Method: X-RAY DIFFRACTION (2.55 Å) Cite: Bringing the Heavy Chain to Light: Creating a Symmetric, Bivalent IgG-Like Bispecific. Antibodies, 9, 2020
7U4P	Covalently stabilized triangular trimer composed of Abeta17-36 beta-hairpins Descriptor: Amyloid-beta 17-36 peptide Authors: Kreutzer, A.G, Haerianardakani, S, Nowick, J.S. Deposit date: 2022-02-28 Release date: 2023-03-15 Last modified: 2024-03-27 Method: X-RAY DIFFRACTION (1.803 Å) Cite: Antibodies Raised Against an A beta Oligomer Mimic Recognize Pathological Features in Alzheimer's Disease and Associated Amyloid-Disease Brain Tissue. Acs Cent.Sci., 10, 2024
3EYO	Crystal structure of anti-human cytomegalovirus antibody 8F9 Descriptor: 8f9 Fab, AD-2 Authors: Thomson, C.A, Bryson, S, McLean, G.R, Creagh, A.L, Pai, E.F, Schrader, J.W. Deposit date: 2008-10-21 Release date: 2008-12-16 Last modified: 2023-09-06 Method: X-RAY DIFFRACTION (2.5 Å) Cite: Germline V-genes sculpt the binding site of a family of antibodies neutralizing human cytomegalovirus. Embo J., 27, 2008
4IJ3	Oxidoreductase Fragment of Human QSOX1 in Complex with a FAB Fragment from an Anti- Human QSOX1 Antibody Descriptor: Heavy chain of FAB fragment, Light chain of FAB fragment, PHOSPHATE ION, ... Authors: Fass, D, Grossman, I. Deposit date: 2012-12-21 Release date: 2013-11-06 Last modified: 2023-11-08 Method: X-RAY DIFFRACTION (2.7 Å) Cite: An Inhibitory Antibody Blocks the First Step in the Dithiol/Disulfide Relay Mechanism of the Enzyme QSOX1. J.Mol.Biol., 425, 2013
5UK1	CryoEM structure of an influenza virus receptor-binding site antibody-antigen interface - Class 3 Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Hemagglutinin HA1, ... Authors: Liu, Y, Pan, J, Caradonna, T, Jenni, S, Raymond, D.D, Schmidt, A.G, Harrison, S.C, Grigorieff, N. Deposit date: 2017-01-19 Release date: 2017-05-31 Last modified: 2020-07-29 Method: ELECTRON MICROSCOPY (4.8 Å) Cite: CryoEM Structure of an Influenza Virus Receptor-Binding Site Antibody-Antigen Interface. J. Mol. Biol., 429, 2017
4UU9	Crystal structure of the human c5a in complex with MEDI7814 a neutralising antibody Descriptor: COMPLEMENT C5, MEDI7814, SULFATE ION Authors: Colley, C, Sridharan, S, Dobson, C, Popovic, B, Debreczeni, J.E, Hargreaves, D, Edwards, B, Brennan, J, England, L, Fung, S, An Eghobamien, L, Sivars, U, Woods, R, Flavell, L, Renshaw, G.J, Wickson, K, Wilkinson, T, Davies, R, Bonnell, J, Warrener, P, Howes, R, Vaughan, T. Deposit date: 2014-07-25 Release date: 2015-08-12 Last modified: 2019-02-27 Method: X-RAY DIFFRACTION (2.12 Å) Cite: Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors. MAbs, 10, 2018

<35363738394041424344454647484950>